Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

1.

An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors.

Savinainen JR, Saario SM, Niemi R, Järvinen T, Laitinen JT.

Br J Pharmacol. 2003 Dec;140(8):1451-9. Epub 2003 Nov 17.

PMID:
14623770
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes.

Dennis I, Whalley BJ, Stephens GJ.

Br J Pharmacol. 2008 Jul;154(6):1349-58. doi: 10.1038/bjp.2008.190. Epub 2008 May 19.

PMID:
18493244
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Reciprocal inhibition of G-protein signaling is induced by CB(1) cannabinoid and GABA(B) receptor interactions in rat hippocampal membranes.

Cinar R, Freund TF, Katona I, Mackie K, Szucs M.

Neurochem Int. 2008 Jun;52(8):1402-9. doi: 10.1016/j.neuint.2008.02.005. Epub 2008 Feb 29.

PMID:
18407377
[PubMed - indexed for MEDLINE]
6.

The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.

Erdozain AM, Diez-Alarcia R, Meana JJ, Callado LF.

Biochem Pharmacol. 2012 Jan 15;83(2):260-8. doi: 10.1016/j.bcp.2011.10.018. Epub 2011 Nov 7.

PMID:
22093909
[PubMed - indexed for MEDLINE]
7.

Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.

Paugh SW, Cassidy MP, He H, Milstien S, Sim-Selley LJ, Spiegel S, Selley DE.

Mol Pharmacol. 2006 Jul;70(1):41-50. Epub 2006 Mar 29.

PMID:
16571654
[PubMed - indexed for MEDLINE]
Free Article
8.
9.

PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.

Horswill JG, Bali U, Shaaban S, Keily JF, Jeevaratnam P, Babbs AJ, Reynet C, Wong Kai In P.

Br J Pharmacol. 2007 Nov;152(5):805-14. Epub 2007 Jun 25.

PMID:
17592509
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.

Griffin G, Atkinson PJ, Showalter VM, Martin BR, Abood ME.

J Pharmacol Exp Ther. 1998 May;285(2):553-60.

PMID:
9580597
[PubMed - indexed for MEDLINE]
Free Article
12.

Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats.

DiPatrizio NV, Simansky KJ.

J Neurosci. 2008 Sep 24;28(39):9702-9. doi: 10.1523/JNEUROSCI.1171-08.2008.

PMID:
18815256
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Allosteric modulation and constitutive activity of fusion proteins between the adenosine A1 receptor and different 351Cys-mutated Gi alpha-subunits.

Klaasse E, de Ligt RA, Roerink SF, Lorenzen A, Milligan G, Leurs R, IJzerman AP.

Eur J Pharmacol. 2004 Sep 19;499(1-2):91-8.

PMID:
15363955
[PubMed - indexed for MEDLINE]
14.

The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.

da Fonseca Pacheco D, Klein A, de Castro Perez A, da Fonseca Pacheco CM, de Francischi JN, Duarte ID.

Br J Pharmacol. 2008 Jul;154(5):1143-9. doi: 10.1038/bjp.2008.175. Epub 2008 May 12.

PMID:
18469844
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids.

Breivogel CS, Walker JM, Huang SM, Roy MB, Childers SR.

Neuropharmacology. 2004 Jul;47(1):81-91.

PMID:
15165836
[PubMed - indexed for MEDLINE]
16.

Inhibitory effects of SR141716A on G-protein activation in rat brain.

Sim-Selley LJ, Brunk LK, Selley DE.

Eur J Pharmacol. 2001 Mar 2;414(2-3):135-43.

PMID:
11239913
[PubMed - indexed for MEDLINE]
17.

Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.

Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A.

Int J Neuropsychopharmacol. 2010 Apr;13(3):373-86. doi: 10.1017/S146114570999023X. Epub 2009 Jul 17.

PMID:
19607756
[PubMed - indexed for MEDLINE]
18.
19.

Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.

Steffens M, Szabo B, Klar M, Rominger A, Zentner J, Feuerstein TJ.

Neuroscience. 2003;120(2):455-65.

PMID:
12890515
[PubMed - indexed for MEDLINE]
20.

5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.

Odagaki Y, Toyoshima R.

Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):335-45. Epub 2006 Feb 21.

PMID:
16491386
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk